Text of MO SJR 23 (2025)
Establishes the "Reproductive Health Care Protection Act"
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
4,415 characters
FIRST REGULAR SESSION
SENATE JOINT RESOLUTION NO. 23
103RD GENERAL ASSEMBLY
INTRODUCED BY SENATOR SCHROER.
1204S.01I
KRISTINA MARTIN, Secretary
JOINT RESOLUTION
Submitting to the qualified voters of Missouri, an amendment to article I of the Constitution of
Missouri, by adding thereto one new section relating to reproductive health care.
Be it resolved by the Senate, the House of Representatives concurring therein:
That at the next general election to be held in the
1
state of Missouri, on Tuesday next following the first Monday
2
in November, 2026, or at a special election to be called by
3
the governor for that purpose, there is hereby submitted to
4
the qualified voters of this state, for adoption or
5
rejection, the following amendment to article I of the
6
Constitution of the state of Missouri:
7
Section A. Article I, Constitution of Missouri, is amended
1
by adding thereto one new section, to be known as section 36(a),
2
to read as follows:
3
Section 36(a). 1. The provisions of this section
1
shall be known and may be cited as the "Reproductive Health
2
Care Protection Act".
3
2. Notwithstanding any provision of section 36 of
4
article I of this Constitution to the contrary, the right to
5
reproductive freedom shall not be construed to include:
6
(1) The performance of gender transition surgeries or
7
the prescription or administration of cross-sex hormones or
8
puberty-blocking drugs for the purpose of gender transition;
9
and
10
SJR 23
2
(2) The payment for the performance or inducement, or
11
assistance with the performance or inducement, of abortions
12
by taxpayers, except in cases of medical emergencies.
13
3. Notwithstanding any provision of section 36 of
14
article I of this Constitution to the contrary, the right to
15
reproductive freedom shall not be construed to exempt any
16
person, firm, or corporation from civil liability for
17
medical malpractice, negligence, or wrongful death.
18
4. The general assembly shall have the authority to
19
enact laws to carry out the provisions of this section.
20
5. As used in this section, the following terms mean:
21
(1) "Cross-sex hormones", testosterone, estrogen, or
22
other androgens given to an individual in amounts that are
23
greater or more potent than would normally occur naturally
24
in a healthy individual of the same age and sex, but shall
25
not include hormones used to treat individuals born with a
26
medically-verifiable disorder of sex development or the
27
treatment of any infection, injury, disease, or disorder
28
unrelated to the purpose of gender transition;
29
(2) "Gender transition surgery", a surgical procedure
30
performed for the purpose of assisting an individual with
31
identifying with and living as a gender different from his
32
or her biological sex, but shall not include surgical
33
procedures for individuals born with a medically-verifiable
34
disorder of sex development or the treatment of any
35
infection, injury, disease, or disorder unrelated to the
36
purpose of gender transition;
37
(3) "Medical emergency", a condition which, based on
38
reasonable medical judgment, so complicates the medical
39
condition of a pregnant woman as to necessitate the
40
immediate abortion of her pregnancy to avert the death of
41
the pregnant woman or for which a delay will create a
42
SJR 23
3
serious risk of substantial and irreversible physical
43
impairment of a major bodily function of the pregnant woman;
44
(4) "Puberty-blocking drugs", gonadotropin-releasing
45
hormone analogues or other synthetic drugs used to stop
46
luteinizing hormone secretion and follicle stimulating
47
hormone secretion, synthetic antiandrogen drugs to block the
48
androgen receptor, or any other drug used to delay or
49
suppress pubertal development in children for the purpose of
50
assisting an individual with a gender transition, but shall
51
not include drugs used to treat individuals born with a
52
medically-verifiable disorder of sex development or the
53
treatment of any infection, injury, disease, or disorder
54
unrelated to the purpose of gender transition.
55